Systematic review| Volume 87, ISSUE 3, P318-325, June 2008

Download started.


Intraoperative radiotherapy in pancreatic cancer: A systematic review

  • Alberto Ruano-Ravina
    Corresponding author. Alberto Ruano-Ravina, Agencia de Evaluación de Tecnologı´as Sanitarias de Galicia, Consellerı´a de Sanidade, Edif Administrativo de San Lázaro, San Lázaro s/n, 15781 Santiago de Compostela, Spain.
    Galician Agency for Health Technology Assessment, Galician Health Authority, Santiago de Compostela, Spain, Spain

    Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain, Spain

    CIBER de Epidemiologı´a y Salud Pública, Spain, Spain
    Search for articles by this author
  • Raquel Almazán Ortega
    Research Unit, Ourense Hospital Complex, Ourense, Spain, Spain
    Search for articles by this author
  • Ferrran Guedea
    Department of Radiation Oncology, University of Barcelona, Spain
    Search for articles by this author
Published:January 16, 2008DOI:


      Background and purpose: Intraoperative radiotherapy (IORT) has been considered for treatment of pancreas cancer since local recurrence rates are very high. This study assesses the efficacy and safety of IORT in pancreatic cancer. Materials and methods: We conducted a systematic review of scientific literature from January 1995 to February 2007, including Medline, Embase, ISI Web of Science and HTA (Health Technology Assessment). By applying a series of inclusion criteria, two independent reviewers selected those studies in which a minimum of 30 patients received IORT and which furnished survival results based on a minimum 3-month follow-up. Results: Fourteen papers were included, one was an IORT assessment report, 5 were cohort studies, and the remaining 8 were case series studies, 2 of which belonged to the same series. In general, these studies showed that IORT could slightly increase survival among patients with pancreatic cancer in localized stages. However, the results were not conclusively in favor of IORT in the case of pancreatic cancer in locally advanced and metastatic stages. There were no published studies that assessed quality of life. Conclusions: There is no clear evidence to indicate that IORT is more effective than other therapies in treating pancreatic cancer in locally advanced and metastatic stages.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Parkin D.M.
        • Bray F.
        • Ferlay J.
        • Pisani P.
        Global cancer statistics, 2002.
        CA Cancer J Clin. 2005; 55: 74-108
        • Greenlee R.T.
        • Murray T.
        • Bolden S.
        • Wingo P.A.
        Cancer statistics, 2000.
        CA Cancer J Clin. 2000; 50: 7-33
      1. National Cancer Institute. Pancreatic Cancer (PDQ): treatment. 2007 15.03.2007 [cited 16.04.2007]. Available from:

        • Yeo C.J.
        • Cameron J.L.
        • Sohn T.A.
        • Lillemoe K.D.
        • Pitt H.A.
        • Talamini M.A.
        • et al.
        Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.
        Ann Surg. 1997; 226 ([Discussion 57–60]): 248-257
        • Conlon K.C.
        • Klimstra D.S.
        • Brennan M.F.
        Long-term survival after curative resection for pancreatic ductal adenocarcinoma Clinicopathologic analysis of 5-year survivors.
        Ann Surg. 1996; 223: 273-279
        • Trede M.
        • Schwall G.
        • Saeger H.D.
        Survival after pancreatoduodenectomy 118 consecutive resections without an operative mortality.
        Ann Surg. 1990; 211: 447-458
        • Geer R.J.
        • Brennan M.F.
        Prognostic indicators for survival after resection of pancreatic adenocarcinoma.
        Am J Surg. 1993; 165 ([Discussion 3]): 68-72
        • Lim J.E.
        • Chien M.W.
        • Earle C.C.
        Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
        Ann Surg. 2003; 237: 74-85
        • Wagner M.
        • Redaelli C.
        • Lietz M.
        • Seiler C.A.
        • Friess H.
        • Buchler M.W.
        Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
        Br J Surg. 2004; 91: 586-594
        • Yamaguchi K.
        • Nakamura K.
        • Kobayashi K.
        • Nakano K.
        • Koniomi H.
        • Mizumoto K.
        • et al.
        ERT following IORT improves survival of patients with resectable pancreatic cancer.
        Hepatogastroenterology. 2005; 52: 1244-1249
      2. Radioterapia Intraoperatoria. Informe de evaluación no 22: Agencia de Evaluación de Tecnologı´as Sanitarias. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo; 1999.

        • Sindelar W.F.
        • Kinsella T.J.
        Normal tissue tolerance to intraoperative radiotherapy.
        Surg Oncol Clin N Am. 2003; 12: 925-942
        • Harris R.P.
        • Helfand M.
        • Woolf S.H.
        • Lohr K.N.
        • Mulrow C.D.
        • Teutsch S.M.
        Current methods of the U.S. Preventive Services Task Force: a review of the process.
        Am J Prev Med. 2001; 20: 31-45
        • Hiraoka T.
        • Kanemitsu K.
        Value of extended resection and intraoperative radiotherapy for resectable pancreatic cancer.
        World J Surg. 1999; 23: 930-936
        • Takamori H.
        • Hiraoka T.
        • Kanemitsu K.
        • Tsuji T.
        • Hamada C.
        • Baba H.
        Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer – under-analysis of cumulative survival curve.
        World J Surg. 2006; 30: 213-218
        • O’Connor J.K.
        • Sause W.T.
        • Hazard L.J.
        • Belnap L.P.
        • Noyes R.D.
        Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
        Int J Radiat Oncol Biol Phys. 2005; 63: 1060-1066
        • Okamoto A.
        • Matsumoto G.
        • Tsuruta K.
        • Baba H.
        • Karasawa K.
        • Kamisawa T.
        • et al.
        Intraoperative radiation therapy for pancreatic adenocarcinoma: the Komagome Hospital experience.
        Pancreas. 2004; 28: 296-300
        • Reni M.
        • Panucci M.G.
        • Ferreri A.J.
        • Balzano G.
        • Passoni P.
        • Cattaneo G.M.
        • et al.
        Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma.
        Int J Radiat Oncol Biol Phys. 2001; 50: 651-658
        • Ma H.B.
        • Di Z.L.
        • Wang X.J.
        • Kang H.F.
        • Deng H.C.
        • Bai M.H.
        Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic carcinoma.
        World J Gastroenterol. 2004; 10: 1669-1771
        • Sunamura M.
        • Karasawa K.
        • Okamoto A.
        • Ogata Y.
        • Nemoto K.
        • Hosotani R.
        • et al.
        Phase III trial of radiosensitizer PR-350 combined with intraoperative radiotherapy for the treatment of locally advanced pancreatic cancer.
        Pancreas. 2004; 28: 330-334
        • Mohiuddin M.
        • Regine W.F.
        • Stevens J.
        • Rosato F.
        • Barbot D.
        • Biermann W.
        • et al.
        Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas.
        J Clin Oncol. 1995; 13: 2764-2768
        • Ihse I.
        • Andersson R.
        • Ask A.
        • Ewers S.B.
        • Lindell G.
        • Tranberg K.G.
        Intraoperative radiotherapy for patients with carcinoma of the pancreas.
        Pancreatology. 2005; 5: 438-442
        • Furuse J.
        • Kinoshita T.
        • Kawashima M.
        • Ishii H.
        • Nagase M.
        • Konishi M.
        • et al.
        Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
        Cancer. 2003; 97: 1346-1352
        • Takahashi S.
        • Aiura K.
        • Saitoh J.
        • Hayatsu S.
        • Kitajima M.
        • Ogata Y.
        Treatment strategy for pancreatic head cancer: pylorus-preserving pancreatoduodenectomy, intraoperative radiotherapy and portal catheterization.
        Digestion. 1999; 60: 130-134
        • Kasperk R.
        • Klever P.
        • Andreopoulos D.
        • Schumpelick V.
        Intraoperative radiotherapy for pancreatic-carcinoma.
        Br J Surg. 1995; 82: 1259-1261
        • Hiraoka T.
        • Uchino R.
        • Kanemitsu K.
        • Toyonaga M.
        • Saitoh N.
        • Nakamura I.
        • et al.
        Combination of intraoperative radiation with resection of cancer of the pancreas.
        Int J Pancreatol. 1990; 7: 201-207
        • Abe M.
        • Takahashi M.
        • Yabumoto E.
        • Onoyama Y.
        • Torizuka K.
        Techniques, indications and results of intraoperative radiotherapy of Advanced Cancers.
        Radiology. 1975; 116: 693-702